Save 20% on Press Releases and More with NNW Prime! Click to View Details
MondayNov 04, 2024 12:48 pm

NetworkNewsBreaks – Blockchain Africa Conference 2024 to Showcase Latest Trends in Cryptocurrencies, Blockchain Technology

Blockchain Africa Conference 2024 is slated to take place at the CSIR International Convention Centre in Pretoria (Tshwane) on Nov. 20, 2024. The event, marking the 10th edition and organized by Bitcoin Events, will unite blockchain developers, influencers, investors, entrepreneurs, and business leaders from around the world. Designed to foster collaboration and provide insights into Africa's dynamic and rapidly evolving blockchain and crypto ecosystem, the conference offers a platform for networking and knowledge sharing, bringing together local and international experts to discuss the most significant trends. Among the many highlights, the event will feature engaging keynote speakers, panel sessions with…

Continue Reading

MondayNov 04, 2024 12:20 pm

NetworkNewsBreaks – Insights into Match Group Inc.’s (NASDAQ: MTCH) Upcoming Earnings Release

Match Group (NASDAQ: MTCH) is a leading provider of online dating services, operating popular platforms like Tinder, Match.com and OkCupid. As the company gears up for its third-quarter earnings release for the period ending September 2024, analysts are keen to delve into metrics beyond the usual revenue and earnings per share (“EPS”) figures. These metrics can offer a more nuanced view of Match Group’s operational strengths and challenges. One key metric is Match Group’s price-to-earnings (“P/E”) ratio, which stands at 14.82. This ratio helps investors understand how much they are paying for each dollar of earnings. A P/E ratio of…

Continue Reading

MondayNov 04, 2024 12:03 pm

NetworkNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) to Report Q3 Financial Results and Host Investor Call

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leading quantum computing company, will release its financial results for the third quarter of fiscal year 2024 ended September 30, 2024 on November 14, prior to market opening. Following the release, D-Wave will hold a conference call at 8 a.m. ET, featuring CEO Dr. Alan Baratz and CFO John Markovich, to discuss the financial results and provide insights into the company’s business outlook. Investors can join the call through the dial-in numbers provided via the press release. To view the full press release, visit https://nnw.fm/Ub0ux About D-Wave Quantum Inc. D-Wave is a leader in…

Continue Reading

MondayNov 04, 2024 11:10 am

NetworkNewsBreaks – Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) to Present Project Developments in Upcoming Live Webinar with Red Cloud Financial Services

Fathom Nickel (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) will host a live virtual corporate update with Red Cloud Financial Services on Nov. 6, 2024, at 2 p.m. ET. CEO and VP of Exploration will provide insights on the company’s advancements at the Gochager Lake and Albert Lake projects, focusing on nickel, copper, cobalt, and platinum group elements (PGEs). The presentation will include a live Q&A session, and a replay will be available to all registrants via email and on Red Cloud’s website. To view the full press release, visit https://nnw.fm/32jvV About Fathom Nickel Inc. Fathom is a junior exploration company…

Continue Reading

MondayNov 04, 2024 10:07 am

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Highlights Berubicin’s Potential in Glioblastoma Treatment During KOL Connect Event

CNS Pharmaceuticals (NASDAQ: CNSP), focused on innovative cancer therapies for brain and central nervous system cancers, recently participated in a Virtual Investor KOL Connect segment featuring Professor Michael Weller, a renowned neuro-oncologist and National Coordinating Investigator for CNS’s study on Berubicin. During the event, Professor Weller discussed the urgent need for effective treatments in glioblastoma multiforme (“GBM”), exploring how Berubicin could serve as a promising therapy within the current limited treatment landscape for this aggressive brain cancer. To view the full press release, visit https://nnw.fm/bBQjh About CNS Pharmaceuticals Inc. CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of…

Continue Reading

MondayNov 04, 2024 9:15 am

NetworkNewsBreaks – Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF) Boosts SASB Gas Field Output with Velocity String Installations

Trillion Energy International (CSE: TCF) (OTCQB: TRLEF) has reported increased production at the SASB gas field following the recent installation of velocity strings (“VS”) aimed at enhancing gas flow by reducing water loading. The Akcakoca-3 well showed an increase in production from approximately 2.0 MMcf/d to 2.6 MMcf/d after VS installation. A velocity string was also installed in the West Akcakoca-1 well, with gas production expected to resume soon after nitrogen stimulation. Trillion is currently installing a VS in the Guluc-2 well as part of the ongoing optimization program at the SASB field. To view the full press release, visit…

Continue Reading

FridayNov 01, 2024 3:31 pm

NetworkNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) to Attend Sportico’s “Invest in Sports” Conference in NYC to Explore Sports Investment Opportunities

Brera Holdings (NASDAQ: BREA) the only publicly traded multi-club ownership company focused on football, will participate in Sportico's “Invest in Sports” Conference in New York City on November 4. Brera’s CEO Pierre Galoppi and Head of Investments Maria Xing will join prominent industry leaders, investors, and executives, including Blackstone’s David Blitzer and sports investor Alexis Ohanian, in discussing the evolving dynamics and growth of sports investments. The conference will cover how sports franchises have expanded into global brands across technology, finance, and real estate, while spotlighting rising sectors like women’s sports and youth athletics. To view the full press release,…

Continue Reading

FridayNov 01, 2024 3:25 pm

NetworkNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Schedules Q3 2024 Financial Results Call with Management Insights and Q&A Session

McEwen Mining (NYSE: MUX) (TSX: MUX) will host a conference call on Wednesday, Nov. 6, 2024, at 11 a.m. EST to discuss its third-quarter 2024 financial results and provide updates on project developments. Following the management’s presentation, participants will have the opportunity to engage directly by asking questions over the phone during the live webcast, offering an interactive session to address investor inquiries and insights. To view the full press release, visit https://nnw.fm/AKDHJ About McEwen Mining Inc. McEwen Mining is a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina. In addition, the company owns approximately 47.7%…

Continue Reading

FridayNov 01, 2024 12:21 pm

NetworkNewsBreaks – Meta Platforms Inc. (NASDAQ: META) Surpasses Q3 Earnings Expectations

Meta (NASDAQ: META) has delivered impressive third-quarter earnings, exceeding Wall Street’s expectations in both revenue and profit. Despite this strong financial performance, the stock has seen a decline. Analysts are concerned about potential new capital expenditure issues related to AI within the Big Tech sector. Currently, META’s stock price stands at $569.79, marking a 0.39% increase or $2.21. The stock has fluctuated today, trading between $562.58 and $573.25. Over the past year, META has seen a high of $602.95 and a low of $311.02. This volatility reflects the market’s mixed sentiment despite the company’s strong earnings. Meta’s market capitalization is…

Continue Reading

FridayNov 01, 2024 9:35 am

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Granted Nasdaq Extension for Compliance

CNS Pharmaceuticals (NASDAQ: CNSP) announced that it received an exception from the Nasdaq Hearings Panel, granting the company until March 11, 2025, to meet the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). This extension allows CNS additional time to regain compliance and maintain its listing status. To view the full press release, visit https://nnw.fm/XfYXS About CNS Pharmaceuticals Inc. CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system. The company’s lead drug candidate, Berubicin, is a novel anthracycline and…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217